Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Cash from Operations (2024 - 2026)

Carlsmed posted quarterly Cash from Operations of 13007000.0 for Q1 2026, down 59.5% year-on-year from 32113861.64 in Q1 2025, and down 144.45% on a QoQ basis from 5321000.0 in Q4 2025.

Carlsmed (CARL) has 3 years of Cash from Operations data on file, last reported at 13007000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Operations fell 59.5% year-over-year to 13007000.0; the trailing twelve-month figure through Mar 2026 stood at 33829000.0 (changed N/A YoY), and the FY2025 full-year result was 28977000.0, down 13.79% from the prior year.
  • Cash from Operations for Q1 2026 stood at 13007000.0, down from 5321000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 4203000.0 in Q4 2024 and bottomed at 13007000.0 in Q1 2026.
  • The 3-year median for Cash from Operations is 7580000.0 (2024), against an average of 7681000.0.
  • The widest annual swing landed in 2025, when Cash from Operations declined 11.6%; it then slumped 59.5% in 2026.
  • A 3-year view of Cash from Operations shows it stood at 4203000.0 in 2024, then dropped by 26.6% to 5321000.0 in 2025, then tumbled by 144.45% to 13007000.0 in 2026.
  • The last three Cash from Operations figures came in at 13007000.0 (Q1 2026), 5321000.0 (Q4 2025), and 8459000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 106.85 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 122.94 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 97.53 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 43.08 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 109.52 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 84.91 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 26.12 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -49.47 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 54.50 Mn
10 Carlsmed 298.68 Mn 201.48 Mn 12.43 Mn -13.01 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -13.01 Mn
Mar 31, 2026 -13.01 Mn
Dec 31, 2025 -5.32 Mn
Dec 31, 2025 -5.32 Mn
Sep 30, 2025 -8.46 Mn
Sep 30, 2025 -8.46 Mn
Jun 30, 2025 -7.04 Mn
Jun 30, 2025 -7.04 Mn
Mar 31, 2025 -8.16 Mn
Mar 31, 2025 -8.16 Mn
Dec 31, 2024 -4.20 Mn
Dec 31, 2024 -4.20 Mn
Sep 30, 2024 -7.58 Mn
Sep 30, 2024 -7.58 Mn